Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 29, 2017
NLP text analytics provider Linguamatics has announced a partnership with news content provider Dow Jones. The agreement allows pharmaceutical companies to extract key insights from Dow Jones Factiva utilizing Linguamatics I2E text mining technology.
read more
LineaRx has shipped multiple customized linear DNA amplicons to Evotec SE, a therapeutic development company, to support their research efforts related to neurodegenerative diseases.
read more
Thursday, December 12, 2024
Lindus Healthhas launched their “all-in-one” contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.
read more
Tuesday, December 16, 2025
Lindus Health and Quotient Sciences announced a strategic partnership to enable innovative biotech and pharma sponsors with enhanced patient recruitment for Phase I-IIa clinical studies and a seamless pathway from first-in-human (FIH) to proof-of ...
read more
Tuesday, February 18, 2025
Lindus Health has announced a collaboration with the Clinical Data Interchange Standards Consortium (CDISC), to accelerate the generation of standardized concepts using AI. CDISC is an organization that develops data standards to streamline the ...
read more
Tuesday, November 24, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement.
read more
Thursday, August 01, 2013
In an effort to increase the number of minority investigators in clinical research, Eli Lilly and Company and The Center for Drug Development and Clinical Trials at Roswell Park Cancer Institute (RPCI) today announced a new collaborative training ...
read more
Monday, February 22, 2021
Eli Lilly and Rigel announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552.
read more
Thursday, November 01, 2012
Local and state government officials joined representatives from Eli Lilly and Company today to announce a $140 million expansion to the company's Indianapolis insulin manufacturing operations. The 80,000-square-foot expansion, which will enable the...
read more
Wednesday, March 04, 2020
Among the concerns raised due to the impact of the novel coronavirus is whether patients can count on a reliable supply of medicine.
read more
Eli Lilly has committed another 780,000 vials of insulin to the International Diabetes Federation's Life for a Child program.
read more
Eli Lilly and Company has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, as well as a manufacturing facility in Suzhou, China to Eddingpharm.
read more
Eli Lilly and Company (NYSE: LLY) today announced it will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This website, which houses data from several clinical trial sponsors, was created in...
read more
Eli Lilly and Company announced a three-year extension of its cancer research collaboration with Dana-Farber Cancer Institute.
read more
Wednesday, January 27, 2016
Eli Lilly and Company has announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
read more